10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus

ADVERTISEMENT

Statin Use: The Cancer-Causing Mistake 1 in 4 People Over 45 Make

Statin Use: The Cancer-Causing Mistake 1 in 4 People Over 45 Make

Story at-a-glance -

  • A recent study found that use of any statin drug, in any amount, was associated with a significantly increased risk for prostate cancer
  • Findings from previous studies investigating the statin-cancer link have been mixed, but a number of studies over the past 15 years have raised warnings over such a potential link
  • Current cholesterol guidelines, which recommend LDL levels of less than 100 or even less than 70 for patients at very high risk of heart disease, are <i>dangerously</i> low, and are likely doing far more harm than good
  • While reducing your risk of heart disease is the primary motivation for prescribing statins, these drugs can actually <i>increase</i> your risk of heart disease because they deplete your body of CoQ10, which can lead to heart failure. If you’re on statin drug therapy, you must also take a CoQ10 or ubiquinol supplement to stave off irreparable mitochondrial damage
  • Statin drugs do <i>not</i> modulate LDL particle size, and particle size is the factor that can make LDL “bad” in the first place. Small LDL particles get easily stuck and cause chronic inflammation, which raises your risk of heart disease, while large, buoyant LDL particles do not have such adverse effects. Particle size can only be modulated through dietary intervention

By Dr. Mercola

Statins, drugs that lower your cholesterol levels, are one of the most widely prescribed drugs in the world.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access